These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9841172)

  • 21. Evaluation of cholesterol absorption in rats using markers labeled with stable isotopes. Effect of complete bile diversion.
    Decker P; Brinkmann JF; Lindenthal B; Hirner A; von Bergmann K
    Hepatogastroenterology; 1998; 45(24):2033-7. PubMed ID: 9951859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypocholesterolemia ].
    Müller G; Schilf K
    Z Gesamte Inn Med; 1987 Jun; 42(11):310-3. PubMed ID: 3660886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on patented cholesterol absorption inhibitors.
    Chhabria MT; Mahajan BM
    Expert Opin Ther Pat; 2009 Aug; 19(8):1083-107. PubMed ID: 19552506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of the cholesterol-lowering effect of water-insoluble fish protein in ovariectomised rats.
    Kato M; Ogawa H; Kishida T; Ebihara K
    Br J Nutr; 2009 Sep; 102(6):816-24. PubMed ID: 19335928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enterohepatic transport of bile salts and genetics of cholestasis.
    Pauli-Magnus C; Stieger B; Meier Y; Kullak-Ublick GA; Meier PJ
    J Hepatol; 2005 Aug; 43(2):342-57. PubMed ID: 15975683
    [No Abstract]   [Full Text] [Related]  

  • 26. Bile salts and its relevance in gastrointestinal disorders.
    J Pak Med Assoc; 1979 Aug; 29(8):163-4. PubMed ID: 117144
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cholesterol absorption as a target for the treatment of hypercholesterolemia].
    Bitzur R; Cohen H; Harats D
    Harefuah; 2006 Nov; 145(11):831-5, 861, 860. PubMed ID: 17183957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular regulation of hepatic bile acid transport in health and cholestasis.
    Anwer MS
    Hepatology; 2004 Mar; 39(3):581-90. PubMed ID: 14999673
    [No Abstract]   [Full Text] [Related]  

  • 29. Physiologic cholestasis.
    Lester R
    Gastroenterology; 1980 Apr; 78(4):864-5. PubMed ID: 7353767
    [No Abstract]   [Full Text] [Related]  

  • 30. Human cholesterol metabolism and therapeutic molecules.
    Charlton-Menys V; Durrington PN
    Exp Physiol; 2008 Jan; 93(1):27-42. PubMed ID: 18165431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ACAT2 gene encodes a gatekeeper of intestinal cholesterol absorption that regulates cholesterolemia and gallstone disease.
    Zanlungo S; Nervi F
    Hepatology; 2001 Mar; 33(3):760-1. PubMed ID: 11230759
    [No Abstract]   [Full Text] [Related]  

  • 32. Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice.
    Pan SY; Yang R; Dong H; Yu ZL; Ko KM
    Eur J Pharmacol; 2006 Dec; 552(1-3):170-5. PubMed ID: 17046746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New-onset severe hypercholesterolemia in a patient with cholestatic liver disease. Should we treat the lipids?
    Papakonstantinou PE; Theodoraki E; Koulentaki M; Papadakis JA
    Hellenic J Cardiol; 2017; 58(4):300-302. PubMed ID: 28137455
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cholesterol metabolism modulators in future drug therapy for atherosclerosis].
    Morozova S; Suc-Royer I; Auwerx J
    Med Sci (Paris); 2005 Dec; 21 Spec No():53-8. PubMed ID: 16598906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of ascorbic acid on the hypercholesterolemia in experimental cholestasis and aminonucleoside nephrosis (author's transl)].
    Froese P; Leipnitz W; Scholz A
    Res Exp Med (Berl); 1975 Jul; 165(2):135-40. PubMed ID: 1224035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulverized cellulose as filling material, especially its effect on serum cholesterol].
    Huth K; Lück M; Stiehl A; Cremer HD
    Verh Dtsch Ges Inn Med; 1973; 79():1270-2. PubMed ID: 4790154
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cholanopathies. Pathogenetic significance of bile acids].
    Matern S; Gerok W
    Med Welt; 1982 Mar; 33(11):393-7. PubMed ID: 7087717
    [No Abstract]   [Full Text] [Related]  

  • 38. Intestinal bile salt absorption in Atp8b1 deficient mice.
    Groen A; Kunne C; Paulusma CC; Kramer W; Agellon LB; Bull LN; Oude Elferink RP
    J Hepatol; 2007 Jul; 47(1):114-22. PubMed ID: 17448567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys.
    Kitayama K; Nakai D; Kono K; van der Hoop AG; Kurata H; de Wit EC; Cohen LH; Inaba T; Kohama T
    Eur J Pharmacol; 2006 Jun; 539(1-2):89-98. PubMed ID: 16687134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat.
    Batta AK; Xu G; Honda A; Miyazaki T; Salen G
    Metabolism; 2006 Mar; 55(3):292-9. PubMed ID: 16483871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.